A Study of Usage of Brigatinib in the Treatment of Adult Participants for Approved Indications In South Korea

Clinical trial NCT04592523 · COMPLETED

Trial details

NCT number: NCT04592523
Sponsor: Takeda
Status: COMPLETED
Study type: OBSERVATIONAL

Carcinoma, Non-Small-Cell Lung Anaplastic Lymphoma Kinase

Start date: 2019-09-05
Primary completion: 2026-03-12
Enrollment: 271

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.